alexa Two-stage adaptive design for clinical trials with survival data.
Pharmaceutical Sciences

Pharmaceutical Sciences

Pharmaceutica Analytica Acta

Author(s): Li G, Shih WJ, Wang Y

Abstract Share this page

Abstract In long-term clinical trials we often need to monitor the patients' enrollment, compliance, and treatment effect during the study. In this paper we take the conditional power approach and consider a two-stage design based on the ideas of Li et al. (2002) for trials with survival endpoints. We make projections and decisions regarding the future course of the trial from the interim data. The decision includes possible early termination of the trial for convincing evidence of futility or efficacy, and projection includes how many additional patients are needed to enroll and how long the enrollment and follow-up may be when continuing the trial. The flexibility of the adaptive design is demonstrated by an example, the Coumadin Aspirin Reinfarction Study. This article was published in J Biopharm Stat and referenced in Pharmaceutica Analytica Acta

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version